THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Engineers Gate Manager LP's Holding History (CIK: 0001620220)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 41,008 Value ($000) $767 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 22,285 Value ($000) $325 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 13,657 Value ($000) $151 Avg Close $9.72 Range $7.90 - $11.82
Q4 2024
Shares 19,832 Value ($000) $187 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 27,025 Value ($000) $218 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 19,477 Value ($000) $165 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 11,921 Value ($000) $107 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 24,979 Value ($000) $281 Avg Close $10.06 Range $8.52 - $11.57
Q3 2021
Shares 18,482 Value ($000) $137 Avg Close $11.19 Range $6.10 - $15.01
Q4 2020
Shares 18,051 Value ($000) $321 Avg Close $17.95 Range $14.48 - $20.53
Q2 2020
Shares 73,667 Value ($000) $1,546 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 40,621 Value ($000) $939 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 35,735 Value ($000) $925 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 27,844 Value ($000) $542 Avg Close $20.20 Range $16.00 - $24.34
Q2 2019
Shares 42,471 Value ($000) $694 Avg Close $20.26 Range $15.18 - $25.38
Q3 2018
Shares 20,262 Value ($000) $662 Avg Close $27.25 Range $22.26 - $32.79